Please use this identifier to cite or link to this item:
Title: The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice
Author: Giralt Torroella, Albert
Gómez Climent, María Ángeles
Alcalá Vida, Rafael
Bretin, Sylvie
Bertrand, Daniel
Delgado Garcia, José M.
Pérez Navarro, Esther
Alberch i Vié, Jordi
Gruart i Massó, Agnès
Keywords: Models animals en la investigació
Malaltia d'Alzheimer
Malalties neurodegeneratives
Receptors de neurotransmissors
Animal models in research
Alzheimer's disease
Neurodegenerative Diseases
Neurotransmitter receptors
Issue Date: 1-Sep-2017
Publisher: Elsevier Ltd
Abstract: Positive allosteric modulators of cc-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) are small molecules that decrease deactivation of AMPARs via an allosteric site. These molecules keep the receptor in an active state. Interestingly, this type of modulator has been proposed for treating cognitive decline in ageing, dementias, and Alzheimer's disease (AD). S 47445 (8-cyclopropyl-3[2-(3-fluorophenyflethy1]-7,8-dihydro-3H-[1,3]oxazino[6,5-g][1,2,3]benzotriazine-4,9-dione) is a novel AMPAR positive allosteric modulator (AMPA-PAM). Here, the mechanisms by which S 47445 could improve synaptic strength and connectivity were studied and compared between young and old mice. A single oral administration of S 47445 at 10 mg/kg significantly increased long-term potentiation (LTP) in CA3-CA1 hippocampal synapses in alert young mice in comparison to control mice. Moreover, chronic treatment with S 47445 at 10 mg/kg in old alert animals significantly counteracted the deficit of LTP due to age. Accordingly, chronic treatment with S 47445 at 10 mg/kg seems to preserve synaptic cytoarchitecture in old mice as compared with young control mice. It was shown that the significant decreases in number and size of pre-synaptic buttons stained for VGlutl, and post-synaptic dendritic spines stained for spinophilin, observed in old mice were significantly prevented after chronic treatment with 10 mg/kg of S 47445. Altogether, by its different effects on LTP, VGlutl-positive particles, and spinophilin, S 47445 is able to modulate both the structure and function of hippocampal excitatory synapses known to be involved in learning and memory processes. These results open a new window for the treatment of specific age-dependent cognitive decline and dementias such as AD. (C) 2017 The Authors. Published by Elsevier Ltd.
Note: Reproducció del document publicat a:
It is part of: Neuropharmacology, 2017, vol. 123, p. 395-409
Related resource:
ISSN: 0028-3908
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
679685.pdf4.5 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons